Emerson Electric (EMR)
was already looking at a slowdown before Covid-19 swept around the
world, but now the company is looking at a much sharper downturn as
automation projects, particularly in petrochemicals, get pushed further.
Management is doing what they’ve done in the past, using the downturn
as an opportunity to streamline and take out costs, but the Street seems
to really dislike the uncertainty as to Emerson’s recovery path in 2021
and beyond.
I don’t think Emerson will see a
2009-style recovery, but I do think many of these projects will
eventually get done, and I think Emerson can benefit from other trends
and drivers like increased automation in industries like food/beverage
and healthcare/biopharma and increased digitalization of process
industries. If Emerson can manage long-term growth of around 2%, these
shares look priced to give investors a solid risk-adjusted return.
Follow this link for more:
Prospects For A "U-Shaped" Recovery Have Hit Emerson Hard
No comments:
Post a Comment